SCI Inks R&D Deal With High Q, Will Make Cell Lines for HD Screening | GenomeWeb
Stem Cell Innovations and the non-profit High Q Foundation this week said they plan to use SCI’s human pluripotent stem cells to develop Huntington's disease-specific cell systems for drug discovery.
Under the terms of the two-year alliance, Houston-based SCI will receive up to $1.1 million from the foundation for reaching certain undisclosed milestones. The company also said it has the right to further use, develop, and commercialize the cell systems resulting from the partnership.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.